Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.7714
+0.00740.97%
Post-market: 0.77160.0002+0.03%17:24 EDT
Volume:1.11M
Turnover:865.39K
Market Cap:124.83M
PE:-3.81
High:0.8208
Open:0.7700
Low:0.7610
Close:0.7640
Loading ...

Ironwood Pharmaceuticals Dismisses Ernst & Young Over Internal Control Weaknesses

Reuters
·
11 Jul

Ironwood Pharmaceuticals Inc. Concluded Annual Stockholders Meeting

Reuters
·
13 Jun

Ironwood Pharmaceuticals Faces Nasdaq Delisting Risk Over Minimum Bid Price Non-Compliance

Reuters
·
04 Jun

CEO Thomas A. McCourt Reports Disposal of Common Shares in Ironwood Pharmaceuticals Inc

Reuters
·
21 May

Ironwood Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Ironwood Pharmaceuticals Q1 Adj. EPS $(0.14) Misses $(0.05) Estimate, Sales $41.14M Miss $45.98M Estimate

Benzinga
·
07 May

BRIEF-Ironwood Pharmaceuticals Q1 Revenue USD 41.143 Million Vs. IBES Estimate USD 46 Million

Reuters
·
07 May

Ironwood Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
05 May

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Business Wire
·
01 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ironwood Pharma (IRWD), AbbVie (ABBV) and Molecular Partners (MOLN)

TIPRANKS
·
29 Apr

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)

TIPRANKS
·
25 Apr

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Business Wire
·
25 Apr

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Business Wire
·
23 Apr

Ironwood Shares Tank on Regulatory Update for Apraglutide

Zacks
·
15 Apr

Ironwood Pharmaceuticals Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
15 Apr

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equalweight From Overweight, Adjusts Price Target to $1 From $7

MT Newswires Live
·
15 Apr

U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group

Reuters
·
15 Apr

Wells downgrades Ironwood to Equal Weight on ‘major setback’

TIPRANKS
·
15 Apr

Ironwood Pharmaceuticals Is Maintained at Market Perform by Leerink Partners

Dow Jones
·
15 Apr

Top Midday Decliners

MT Newswires Live
·
15 Apr